Showing results (531-540 of 559) with videos related to
Sort By:
Pageof 56
Plos One|January 30, 2014
Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysmsPleunie van den Borne, Sander W van der Laan, Sandra M Bovens, et al.Molecular Cancer Therapeutics|March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathwayPeiwen Yu, A Douglas Laird, Xiangnan Du, et al.Cancer Cell|November 12, 2015
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein HomeostasisDaniel J Anderson, Ronan Le Moigne, Stevan Djakovic, et al.Journal of Lipid Research|June 23, 2019
Rare DEGS1 variant significantly alters de novo ceramide synthesis pathwayNicholas B Blackburn, Laura F Michael, Peter J Meikle, et al.Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Frequent introductions and climate suitability drive increasing dengue risk in FloridaEmma Taylor-Salmon, Yi Ting Chew, Rafael Lopes, et al.Molecular Cancer Therapeutics|February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor ModelsPaul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.Bioorganic & Medicinal Chemistry Letters|July 7, 2012
The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitorsMoon H Kim, Amy Lew Tsuhako, Erick W Co, et al.Emerging Infectious Diseases|January 17, 2024
Introduction and Spread of Dengue Virus 3, Florida, USA, May 2022-April 2023Forrest K Jones, Andrea M Morrison, Gilberto A Santiago, et al.Science (New York, N.Y.)|April 28, 2018
Field-deployable viral diagnostics using CRISPR-Cas13Cameron Myhrvold, Catherine A Freije, Jonathan S Gootenberg, et al.Pageof 56